Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kiran Sapkota

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Pharmacology & Therapeutics|October 20, 2019
The origin of NMDA receptor hypofunction in schizophreniaKazu Nakazawa, Kiran Sapkota
Expert Opinion on Biological Therapy|October 20, 2010
Omalizumab for pediatric asthmaRobert G Townley, Swati Agrawal, Kiran Sapkota
Discovery Medicine|December 30, 2011
IL-13 and its genetic variants: effect on current asthma treatmentsRobert G Townley, Muna Sapkota, Kiran Sapkota
Translational Psychiatry|April 23, 2022
5-HT2A receptor dysregulation in a schizophrenia relevant mouse model of NMDA receptor hypofunctionKazuhito Nakao, Mahendra Singh, Kiran Sapkota, et al.
Journal of Medicinal Chemistry|February 16, 2018
Positive and Negative Allosteric Modulators of N-Methyl-d-aspartate (NMDA) Receptors: Structure-Activity Relationships and Mechanisms of ActionErica S Burnell, Mark Irvine, Guangyu Fang, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 18, 2015
GluN2D N-Methyl-d-Aspartate Receptor Subunit Contribution to the Stimulation of Brain Activity and Gamma Oscillations by Ketamine: Implications for SchizophreniaKiran Sapkota, Zhihao Mao, Paul Synowicki, et al.
Neuroscience|January 22, 2023
Maturation of GABAergic Synaptic Transmission From Neocortical Parvalbumin Interneurons Involves N-methyl-D-aspartate Receptor Recruitment of Cav2.1 ChannelsMahendra Singh, Kiran Sapkota, Kenji Sakimura, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 30, 2020
GSK3β inhibition restores cortical gamma oscillation and cognitive behavior in a mouse model of NMDA receptor hypofunction relevant to schizophreniaKazuhito Nakao, Mahendra Singh, Kiran Sapkota, et al.
Scientific Reports|August 2, 2017
A single-channel mechanism for pharmacological potentiation of GluN1/GluN2A NMDA receptorsDivyan A Chopra, Kiran Sapkota, Mark W Irvine, et al.
Bioorganic & Medicinal Chemistry|March 25, 2011
Synthesis and anti-melanogenic activity of hydroxyphenyl benzyl ether analoguesKiran Sapkota, Eunmiri Roh, Eunyoung Lee, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Pharmacology & Therapeutics|October 20, 2019
The origin of NMDA receptor hypofunction in schizophreniaKazu Nakazawa, Kiran Sapkota
Expert Opinion on Biological Therapy|October 20, 2010
Omalizumab for pediatric asthmaRobert G Townley, Swati Agrawal, Kiran Sapkota
Discovery Medicine|December 30, 2011
IL-13 and its genetic variants: effect on current asthma treatmentsRobert G Townley, Muna Sapkota, Kiran Sapkota
Translational Psychiatry|April 23, 2022
5-HT2A receptor dysregulation in a schizophrenia relevant mouse model of NMDA receptor hypofunctionKazuhito Nakao, Mahendra Singh, Kiran Sapkota, et al.
Journal of Medicinal Chemistry|February 16, 2018
Positive and Negative Allosteric Modulators of N-Methyl-d-aspartate (NMDA) Receptors: Structure-Activity Relationships and Mechanisms of ActionErica S Burnell, Mark Irvine, Guangyu Fang, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 18, 2015
GluN2D N-Methyl-d-Aspartate Receptor Subunit Contribution to the Stimulation of Brain Activity and Gamma Oscillations by Ketamine: Implications for SchizophreniaKiran Sapkota, Zhihao Mao, Paul Synowicki, et al.
Neuroscience|January 22, 2023
Maturation of GABAergic Synaptic Transmission From Neocortical Parvalbumin Interneurons Involves N-methyl-D-aspartate Receptor Recruitment of Cav2.1 ChannelsMahendra Singh, Kiran Sapkota, Kenji Sakimura, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 30, 2020
GSK3β inhibition restores cortical gamma oscillation and cognitive behavior in a mouse model of NMDA receptor hypofunction relevant to schizophreniaKazuhito Nakao, Mahendra Singh, Kiran Sapkota, et al.
Scientific Reports|August 2, 2017
A single-channel mechanism for pharmacological potentiation of GluN1/GluN2A NMDA receptorsDivyan A Chopra, Kiran Sapkota, Mark W Irvine, et al.
Bioorganic & Medicinal Chemistry|March 25, 2011
Synthesis and anti-melanogenic activity of hydroxyphenyl benzyl ether analoguesKiran Sapkota, Eunmiri Roh, Eunyoung Lee, et al.
Pageof 2